Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant pleural mesothelioma.

Randall S Hughes1

  • 1Division of Hematology/Oncology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-8852, USA. Randall.Hughes@UTSouthwestern.edu

The American Journal of the Medical Sciences
|January 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HYHOPE: A Phase 1 Study of Deintensified Hypofractionated Radiation Therapy for Human Papillomavirus-Associated Oropharynx Cancer.

International journal of radiation oncology, biology, physics·2025
Same author

Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC: A Multicenter, Randomized Clinical Trial.

International journal of radiation oncology, biology, physics·2025
Same author

Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice.

Frontiers in immunology·2024
Same author

Extracapsular extension, pathologic node status, and adjuvant treatment in primary surgery patients with human papillomavirus-mediated oropharyngeal cancer: National hospital-based retrospective cohort analysis.

Head & neck·2021
Same author

Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks.

Oral oncology·2020
Same author

Unique Patterns of Distant Metastases in HPV-Positive Head and Neck Cancer.

Oncology·2019

Malignant pleural mesothelioma, a rare cancer linked to asbestos, has seen increased incidence. Current treatments have limited impact, prompting research into novel therapies for this asbestos-related disease.

Area of Science:

  • Oncology
  • Epidemiology
  • Environmental Health

Background:

  • Malignant pleural mesothelioma is a rare cancer, with ~3000 US cases annually.
  • Asbestos exposure, identified in 1960, is the primary risk factor.
  • The simian vacuolating virus 40 (SV40) is also a potential cause.

Purpose of the Study:

  • To review the epidemiology and risk factors of malignant pleural mesothelioma.
  • To discuss current treatment modalities and their limitations.
  • To explore emerging therapeutic strategies for mesothelioma.

Main Methods:

  • Literature review of epidemiologic studies on mesothelioma.
  • Analysis of historical data on asbestos exposure and mesothelioma incidence.
  • Overview of current and investigational treatment approaches.

Related Experiment Videos

Main Results:

  • Asbestos exposure is strongly linked to increased mesothelioma incidence.
  • Traditional treatments (surgery, radiotherapy, chemotherapy) offer limited survival benefits.
  • New therapies show promise for both resectable and unresectable cases.

Conclusions:

  • Asbestos remains the principal etiological agent for malignant pleural mesothelioma.
  • Novel therapeutic strategies are crucial for improving patient outcomes.
  • Targeted therapies and multimodality programs represent the future of mesothelioma treatment.